177 related articles for article (PubMed ID: 32822512)
1. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria.
Martí-Andrés G; van Bommel L; Meles SK; Riverol M; Valentí R; Kogan RV; Renken RJ; Gurvits V; van Laar T; Pagani M; Prieto E; Luquin MR; Leenders KL; Arbizu J
Mov Disord; 2020 Nov; 35(11):2009-2018. PubMed ID: 32822512
[TBL] [Abstract][Full Text] [Related]
2. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
3. Automatic covariance pattern analysis outperforms visual reading of
Buchert R; Wegner F; Huppertz HJ; Berding G; Brendel M; Apostolova I; Buhmann C; Dierks A; Katzdobler S; Klietz M; Levin J; Mahmoudi N; Rinscheid A; Rogozinski S; Rumpf JJ; Schneider C; Stöcklein S; Spetsieris PG; Eidelberg D; Wattjes MP; Sabri O; Barthel H; Höglinger G;
Mov Disord; 2023 Oct; 38(10):1901-1913. PubMed ID: 37655363
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
[TBL] [Abstract][Full Text] [Related]
6. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
[TBL] [Abstract][Full Text] [Related]
7. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
[TBL] [Abstract][Full Text] [Related]
8. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
[TBL] [Abstract][Full Text] [Related]
9. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.
Grijalva RM; Pham NTT; Huang Q; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Weigand SD; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
Mov Disord; 2022 Apr; 37(4):702-712. PubMed ID: 34970796
[TBL] [Abstract][Full Text] [Related]
10. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
[TBL] [Abstract][Full Text] [Related]
12. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
13. Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.
Nigro S; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Augimeri A; Quattrone A; Morelli M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
Mov Disord; 2020 Jun; 35(6):976-983. PubMed ID: 32092195
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.
Huppertz HJ; Möller L; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Respondek G; Stamelou M; Schnitzler A; Pinkhardt EH; Oertel WH; Knake S; Kassubek J; Höglinger GU
Mov Disord; 2016 Oct; 31(10):1506-1517. PubMed ID: 27452874
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
Potrusil T; Krismer F; Beliveau V; Seppi K; Müller C; Troger F; Göbel G; Steiger R; Gizewski ER; Poewe W; Scherfler C
Parkinsonism Relat Disord; 2020 Mar; 72():65-71. PubMed ID: 32113070
[TBL] [Abstract][Full Text] [Related]
16. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
Longoni G; Agosta F; Kostić VS; Stojković T; Pagani E; Stošić-Opinćal T; Filippi M
Mov Disord; 2011 Feb; 26(2):247-55. PubMed ID: 21412831
[TBL] [Abstract][Full Text] [Related]
17. Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
Lee Y; Lee DK; Lee JM; Chung SJ; Lee JJ; Sohn YH; Lee PH
Eur J Neurol; 2017 Jan; 24(1):212-218. PubMed ID: 27747983
[TBL] [Abstract][Full Text] [Related]
18. Track density imaging in progressive supranuclear palsy: A pilot study.
Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A
Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903
[TBL] [Abstract][Full Text] [Related]
19. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2023 Feb; 130(2):97-109. PubMed ID: 36701008
[TBL] [Abstract][Full Text] [Related]
20. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
Picillo M; Ricciardi C; Tepedino MF; Abate F; Cuoco S; Carotenuto I; Erro R; Ricciardelli G; Russo M; Cesarelli M; Barone P; Amboni M
Front Neurol; 2021; 12():674495. PubMed ID: 34177779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
